Testosterone supplementation in the aging male

被引:19
作者
Kim, YC
机构
[1] Pundang Je SAeng Gen Hosp, Dae Jin Med Ctr, Ctr Reprod & Genet, Pundang Ku, Kyonggi Do 463050, South Korea
[2] Pundang Je SAeng Gen Hosp, Dept Urol, Dae Jin Med Ctr, Pundang Ku, Kyonggi Do 463050, South Korea
关键词
aging male; hypgonadism; physiology; evaluation; pharmacology; testosterone supplementation;
D O I
10.1038/sj.ijir.3900446
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
World-wide life expectancy at birth for men and women will have increased by about 20 y during 50 y period between 1950 and 2000. As a result, the proportion of the elderly population is expected to increase significantly in the 21st century. Despite this increase in longevity for men and women, men still have significantly shorter life expectancy of approximately 5 y. To further reduce and prevent debilitating disease and disability in elderly men, a question is whether any type of interventions, such as hormone replacement therapy, may play a role in improving the quality of life as proven in post-menopausal women. Men experience age-related decline of capability physically and mentally. Various symptoms, such as nervousness, depression, impaired memory, inability to concentrate, easy fatigability, insomnia, hot flushes, periodic sweating, reduction of muscle mass and power, bone ache, and sexual dysfunction, are related to this change. The fact that a number of age-related changes resemble features of various hormonal deficiency has led to worldwide interest in the use of various hormonal preparations in an effort to prevent the aging process in elderly men. Even though there have been opinions against hormonal supplementation in the aging male, preliminary studies defining the risk/benefit ratio of androgen supplementation appear to be encouraging. To understand testosterone supplementation in the aging male, this review will! discuss the following important topics: physiology of male hormonal balance, changes in reproductive organs in elderly men, endocrine evaluation of the male, pharmacological effects of testosterone on target organs, available preparations for testosterone, and testosterone supplementation.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 57 条
[21]  
Kaiser FE, 1995, HORMONES AGING, P153
[22]   Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism [J].
Katznelson, L ;
Finkelstein, JS ;
Schoenfeld, DA ;
Rosenthal, DI ;
Anderson, EJ ;
Klibanski, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4358-4365
[23]  
KIM YC, 1977, INT J IMPOT RES S1, V9, pS25
[24]  
KORZEKWA KR, 1995, DIABETES METAB, V21, P156
[25]   INCREASED AGGRESSIVE RESPONDING IN MALE-VOLUNTEERS FOLLOWING THE ADMINISTRATION OF GRADUALLY INCREASING DOSES OF TESTOSTERONE CYPIONATE [J].
KOURI, EM ;
LUKAS, SE ;
POPE, HG ;
OLIVA, PS .
DRUG AND ALCOHOL DEPENDENCE, 1995, 40 (01) :73-79
[26]   Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate [J].
Kouri, EM ;
Pope, HG ;
Oliva, PS .
CLINICAL JOURNAL OF SPORT MEDICINE, 1996, 6 (03) :152-157
[27]   RISKS OF BLOOD-VOLUME CHANGES IN HYPOGONADAL MEN TREATED WITH TESTOSTERONE ENANTHATE FOR ERECTILE IMPOTENCE [J].
KRAUSS, DJ ;
TAUB, HA ;
LANTINGA, LJ ;
DUNSKY, MH ;
KELLY, CM .
JOURNAL OF UROLOGY, 1991, 146 (06) :1566-1570
[28]  
LUNENFELD B, 1988, AGING MALE, V1, P1
[29]   Testosterone-induced suppression of lipoprotein(a) in normal men; Relation to basal lipoprotein(a) level [J].
Marcovina, SM ;
Lippi, G ;
Bagatell, CJ ;
Bremner, WJ .
ATHEROSCLEROSIS, 1996, 122 (01) :89-95
[30]   Testosterone and regional fat distribution [J].
Marin, P .
OBESITY RESEARCH, 1995, 3 :S609-S612